Top Markets
Coin of the day
Nanobiotix S.A. Nanobiotix S.A.

Nanobiotix S.A.

NANO
Classement en actions #5950
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on... Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Prix de l'action
$45.79
Capitalisation boursière
$2.33B
Changement (1 jour)
11.43%
Changement (1 an)
408.10%
Pays
FR
Échange Nanobiotix S.A. (NANO)

Catégorie

Historique du prix de l'action pour Nanobiotix S.A. (NANO)
Prix de clôture le plus élevé : $41.65 le 2026-08-01

Prix de clôture le plus bas : $8.60 le 2012-10-01
Historique du prix de l'action de Nanobiotix S.A. de 2012 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 29.51%
2025 582.51%
2024 -45.85%
2023 51.22%
2022 -50.99%
2021 -50.84%
2020 93.52%
2019 -37.58%
2018 -11.94%
2017 -7.30%
2016 -2.69%
2015 -15.40%
2014 172.96%
2013 -14.45%
2012 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$549.16 41.14%
US
$1.06K 49.18%
NL
$122.63 -12.65%
AU
$142.75 468.71%
US
$765.25 7.19%
CH